2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Hiring, retaining, or simply doing business with the wrong people may expose your lab to significant financial penalties.
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
In this OIG roundup, we cover the agency’s plans to modernize and improve the useability of its Compliance Program Guidance, which was first published in 1998.
A proposed move to make noncompete agreements illegal could impact retention of some laboratory employees.
To avoid claims denials and improper billings, ensure billing and coding staff is aware of, and has adjusted to, all recent coding changes.
CMS recently issued long-awaited guidance on post-PHE changes to Medicare coverage of SARS-CoV-2 diagnostic tests.
An overview and analysis of the recently proposed changes and how they could affect your medical laboratory.